PTH and breast carcinoma: Swami et al. showed that this effect of intermittent PTH treatment reduced cancer cell engraftment and incidence of skeletal tumors in vivo in various models involving MDA-MB-231 cells or 4T1 murine human breast cancer tumors, and that it rendered a less metastatic phenotype to the cells.